CDTX vs OGN · rev $1.3M vs P/E 3.4, rev $6.40B
Cidara Therapeutics Inc (CDTX) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
CDTX currently screens at market cap $6.96B. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the CDTX and OGN stock pages for the full models.
Not investment advice.